Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Visual Impairment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT06162585
What this trial is testing

Non-Interventional Long Term Follow-up Study of Participants Previously Enrolled in the RESTORE Study

Who this might be right for
Retinitis PigmentosaRetinitisRetinal Diseases+4 more
Nanoscope Therapeutics Inc. 18
Not applicableStudy completedNCT01262209
What this trial is testing

Clinical Effectiveness of Low Vision Rehabilitation in Glaucoma Patients

Who this might be right for
Glaucoma
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 16
Not applicableStudy completedNCT05246904
What this trial is testing

Validating a Self-fitting Hearing Aid

Who this might be right for
Hearing and Vision Loss
University of Minnesota 41
Not applicableLooking for participantsNCT07337317
What this trial is testing

Evaluating Stairway Designs for Individuals With Vision Impairment

Who this might be right for
Vision, LowMobility Limitation
The University of Alabama in Huntsville 65
Not applicableStudy completedNCT07496606
What this trial is testing

Effect of an Audio Instructional Program Regarding Puberty on Self-Concept and Healthy Behaviors of Teenage Girls With Visual Impairment

Who this might be right for
HealthyTeenagersGirls+1 more
Al-Quds University 46
Large-scale testing (Phase 3)Study completedNCT00687804
What this trial is testing

A 12 Month Core Study to Assess the Efficacy and Safety of Ranibizumab (Intravitreal Injections) in Patients With Visual Impairment Due to Diabetic Macular Edema and a 24 Month Open-label Extension Study

Who this might be right for
Diabetic Macular Edema
Novartis 345
Not applicableLooking for participantsNCT03011541
What this trial is testing

Stem Cell Ophthalmology Treatment Study II

Who this might be right for
Retinal DiseaseAge-Related Macular DegenerationRetinitis Pigmentosa+15 more
MD Stem Cells 500
Not applicableLooking for participantsNCT07322939
What this trial is testing

Effects of Exercise With Visual Feedback in Parkinson's Disease

Who this might be right for
Parkinson DiseaseBalance ImpairmentExercise Training+1 more
Hasan Kalyoncu University 32
Not applicableUnknownNCT05184036
What this trial is testing

Development of an ICT Platform-Awareness System for the Support of Low Vision

Who this might be right for
Low Vision Digital Assistance
Aristotle University Of Thessaloniki 500
Large-scale testing (Phase 3)Study completedNCT02157077
What this trial is testing

Aflibercept After Ranibizumab in Exudative Age-related Macular Degeneration

Who this might be right for
Macular DegenerationWet Macular DegenerationRetinal Degeneration+2 more
Centre Hospitalier Intercommunal Creteil 90
Large-scale testing (Phase 3)Study completedNCT02034006
What this trial is testing

The Criteria Establishing the Need for Re-treatment With Ranibizumab Upon Relapse in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia.

Who this might be right for
Choroidal Neovascularization Secondary to Pathologic Myopia
Novartis Pharmaceuticals 200
Not applicableNot Yet RecruitingNCT03166072
What this trial is testing

Health Education vs Meditation in Irreversible Age-Related Vision Loss Patients and Their Caregivers

Who this might be right for
Low Vision, One Eye, Unspecified EyeLow Vision Blindness
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 150
Not applicableStudy completedNCT00333879
What this trial is testing

Virtual Reality Mobility Training System for Veterans With Vision Loss

Who this might be right for
Blindness
US Department of Veterans Affairs 4
Not applicableStudy completedNCT04984590
What this trial is testing

Early Feasibility Study Using IOPCL MAG to Improve Near Vision in ARMD Subjects

Who this might be right for
Low VisionAge Related Macular Degeneration
OnPoint Vision Inc 9
Post-approval studies (Phase 4)Study completedNCT01580020
What this trial is testing

Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO

Who this might be right for
Retinal Vein Occlusion
Novartis Pharmaceuticals 175
Not applicableWithdrawnNCT06398080
What this trial is testing

An Observational Study to Investigate the Use of Aflibercept 8 mg to Treat Adult Patients With Neovascular Age-Related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME) in a Real-World Setting

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)Wet Age-related Macular Degeneration (AMD)Diabetic Macular Edema (DME)+1 more
Regeneron Pharmaceuticals
Not applicableUnknownNCT02795507
What this trial is testing

Cross Education in Patients With Sensorimotor Impairment

Who this might be right for
Neurological Disorder
Nachum Soroker, MD 40
Not applicableStudy completedNCT00921297
What this trial is testing

Cataract Removal and Alzheimer's Disease

Who this might be right for
CataractsAlzheimer's Disease
University Hospitals Cleveland Medical Center 122
Not applicableStudy completedNCT05936320
What this trial is testing

Evaluating the Effects of Information Leaflets in Adult Aural Rehabilitation

Who this might be right for
Hearing Impairment
Horselvarden Region Ostergotland 61
Large-scale testing (Phase 3)Study completedNCT01171976
What this trial is testing

Efficacy and Safety of Ranibizumab in Two "Treat and Extend" Treatment Algorithms Versus Ranibizumab As Needed in Patients With Macular Edema and Visual Impairment Secondary to Diabetes Mellitus

Who this might be right for
Diabetic Macular Edema
Novartis Pharmaceuticals 373
Next Page